Benvenue Medical Receives Spine Technology Award For Kiva® VCF Treatment System Award from Orthopedics This Week Honors Best Spine Products, Engineers and Inventors

SANTA CLARA, Calif., Oct. 9, 2013 –/PRNewswire/ — Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, won the 2013 Spine Technology Award in the minimally invasive spine care category for its Kiva VCF Treatment System.  The fifth annual Spine Technology Awards are being presented byOrthopedics This Week and RRY Publications LLC at the North American Spine Society (NASS) annual meeting this week in New Orleans. The awards honor innovative spine surgery products and their engineering teams and inventors.

(Logo: http://photos.prnewswire.com/prnh/20110418/SF84532LOGO)

The Kiva VCF Treatment System provides a new approach to the treatment of painful vertebral compression fractures (VCFs) due to osteoporosis. Kiva includes a proprietary flexible implant made from PEEK-OPTIMA^®, a biocompatible polymer that is widely used and well accepted as a spinal implant. The implant is designed to provide structural support to the vertebral body. The implant also functions as a reservoir to contain and direct the flow of bone cement.  Kiva is currently investigational in the United States and is the subject of a pending 510(k). If cleared, Kiva would be the only new implant in the VCF market supported by published, peer-reviewed outcomes from Level I study comparisons to Medtronic’s kyphoplasty devices.  The Kiva VCF Treatment System is commercially available in Europe.

“It is such an honor to receive the Spine Tech Award from Orthopedics This Week from its renowned panel of judges, especially since we understand there were many worthy entries in the minimally invasive spine care category this year,” said Robert K. Weigle, CEO of Benvenue Medical.

About Benvenue Medical, Inc. Founded in 2004, Benvenue Medical, Inc. develops next-generation, minimally invasive expandable implants for the spine. The company is privately held and funded by De Novo Ventures, Domain Associates, Technology Partners and Versant Ventures.  Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $1.6 billion globally. For more information, visit www.benvenuemedical.com.

MEDIA CONTACT: Betsy Merryman Merryman Communicationsbetsy@merrymancommunications.com 310-560-8176